ENTYVIO COMMERCIAL

Patient Portrayal

About the ENTYVIO campaign

Living with ulcerative colitis (UC) or Crohn’s disease is a personal experience where no two patients are alike. In our latest commercial, we heard from real people about their experiences in managing the complex symptoms and their thoughts and emotions on living with a chronic illness. We worked to capture a realistic portrayal of the reminders of their condition, along with the anxieties that come with the challenges in navigating daily life.

Though not everyone with UC or Crohn’s experiences the urgent need to use the bathroom, their day can still be full of reminders of their condition. This campaign is designed to start a conversation about the realities of living with UC or Crohn’s and help patients find relief and remission with a treatment option that supports their lifestyle, either by IV infusion or the ENTYVIO Pen. In the 10-year history of ENTYVIO, we have made it our mission to learn from real people living with UC or Crohn's to better understand and help them.

ENTYVIO
commercial

01:00

Click here for Medication Guide

Constant reminders of your moderate to severe Crohn’s disease or ulcerative colitis can make it hard to be there when it matters most.

[SUPER] For adults with moderate to severe Crohn’s disease or ulcerative colitis (UC). Available by prescription only.

If your symptoms aren’t under control, it may be time to talk to your doctor about #1 prescribed ENTYVIO.

[GRAPHIC] #1 PRESCRIBED BIOLOGIC FOR CROHN’S AND UC*

[SUPER] *For Crohn’s and UC patients combined. Quarterly analysis of claims data from June 2022 to December 2023.

ENTYVIO has helped many people achieve long-term relief and remission.

[GRAPHIC] LONG-TERM RELIEF AND REMISSION

[SUPER] In clinical trials, ENTYVIO helped many patients achieve results at Week 52. Individual results may vary.

Doctors have been prescribing ENTYVIO for more than ten years.

[SUPER] If other treatments haven’t worked well enough, ask your healthcare provider about ENTYVIO.

ENTYVIO offers two maintenance options, including the ENTYVIO Pen.

Infusion and serious allergic reactions can happen during or after treatment.

[SUPER] Infusion and serious allergic reactions can happen during or after treatment.

ENTYVIO may increase risk of infection, which can be serious.

[SUPER] ENTYVIO may increase risk of infection, which can be serious.

PML, a rare, potentially fatal brain infection cannot be ruled out.

[SUPER] PML, a rare, potentially fatal brain infection cannot be ruled out.

Tell your doctor if you have an infection, flu-like symptoms, sores, or are prone to infections.

[SUPER] Tell your doctor if you have an infection, flu-like symptoms, sores, or are prone to infections.

Liver problems can occur.

[SUPER] Liver problems can occur.

Ask your healthcare provider about ENTYVIO. Relief. Remission. For real.

[GRAPHIC] RELIEF. REMISSION. FOR REAL.

ENTYVIO. ENTYVIO. ENTYVIO.

[GRAPHIC] Ask your healthcare provider about THE ENTYVIO PEN.

[Super] To learn more, visit ENTYVIO.COM or call 1.844.ENTYVIO

ENTYVIO
commercial

01:00

Click here for Medication Guide

You weren’t made for moderate to severe Crohn’s disease or ulcerative colitis.

[SUPER] Made for adults with moderate to severe Crohn’s disease or ulcerative colitis (UC).

But ENTYVIO is.

[SUPER] Available by prescription only.

In clinical trials, ENTYVIO helped many people achieve long-term relief and remission.

[GRAPHIC] POTENTIAL FOR LONG-TERM RELIEF AND REMISSION

[SUPER] Long-term remission measured at 52 weeks. Individual results may vary.

Infusion and serious allergic reactions can happen during or after treatment. ENTYVIO may increase risk of infection, which can be serious.

Although unlikely, a risk of PML, a rare, serious, potentially fatal brain infection cannot be ruled out.

[SUPER] ENTYVIO is given by IV infusion in the arm over 30 minutes.

Tell your doctor if you have an infection, experience frequent infections, or have flu-like symptoms or sores. Liver problems can occur.

[SUPER] To learn more, visit Entyvio.com or call 1.844.ENTYVIO

It’s time to ask your healthcare provider about ENTYVIO.

[SUPER] If other treatments haven’t worked well enough, ask your healthcare provider about ENTYVIO.

Go to ENTYVIO.com to learn more about the #1 prescribed biologic for Crohn’s and UC.

[GRAPHIC] #1 PRESCRIBED BIOLOGIC FOR CROHN’S AND UC*

[SUPER] *For Crohn’s and UC patients combined. Data through December 2022.

ENTYVIO, ENTYVIO, ENTYVIO

[SUPER] ELIGIBLE PATIENTS MAY PAY AS LITTLE AS $5 PER DOSE*

*Must meet eligibility requirementss

Entyvio Campaign College

Entyvio Campaign Trucker Diner

How ENTYVIO works

Curious how ENTYVIO helps fight UC? Here’s an easy-to-understand description.

See the science

UC results

See how ENTYVIO helps treat moderate to severe ulcerative colitis.

Get the facts

IMPORTANT SAFETY INFORMATION

Do not receive ENTYVIO^® if you have had an allergic reaction to ENTYVIO or any of its ingredients.
ENTYVIO may cause serious side effects, including:
- Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
- Infections. ENTYVIO may increase your risk of getting a serious infection. Before receiving and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination.
- Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
- Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have tuberculosis (TB) or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.
Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.

Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.

ENTYVIO is available for:

intravenous (IV) infusion: 300 mg vedolizumab.
subcutaneous (SC) injection: 108 mg vedolizumab.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

What is ENTYVIO (vedolizumab)?

ENTYVIO is a prescription medicine used in adults for the treatment of:

moderately to severely active ulcerative colitis (UC).
moderately to severely active Crohn’s disease (CD).

It is not known if ENTYVIO is safe and effective in children under 18 years of age.

Important Safety Information

Do not receive ENTYVIO^® if you have had an allergic reaction to ENTYVIO or any of its ingredients.

ENTYVIO may cause serious side effects, including:

Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
Infections. ENTYVIO may increase your risk of getting a serious infection. Before receiving and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination.
Progressive Multifocal Leukoencephalopathy (PML). People with weakened immune systems can get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be ruled out. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).

The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, pain in extremities, and with injections under the skin: pain, swelling, itching, hives, bruising, rash, or redness at the injection site. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.

Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have tuberculosis (TB) or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, especially if you take or have recently taken Tysabri (natalizumab), Tyruko (natalizumab-sztn), a Tumor Necrosis Factor (TNF) blocker medicine, a medicine that weakens your immune system (immunosuppressant), or corticosteroid medicine.

Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.

ENTYVIO is available for:

intravenous (IV) infusion: 300 mg vedolizumab.

subcutaneous (SC) injection: 108 mg vedolizumab.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

What is ENTYVIO (vedolizumab)?

ENTYVIO is a prescription medicine used in adults for the treatment of:

moderately to severely active ulcerative colitis (UC).

moderately to severely active Crohn’s disease (CD).

It is not known if ENTYVIO is safe and effective in children under 18 years of age.

ENTYVIO COMMERCIAL

About the ENTYVIO campaign

How ENTYVIO works

UC results

You are About to Leave this Website and Enter a Website Operated by an Independent Third Party

You are about to leave this website.

Share with Your Friends and Family: